BioCorRx Inc
Change company Symbol lookup
Select an option...
BICX BioCorRx Inc
NVOS Novo Integrated Sciences Inc
PAYS Paysign Inc
SELB Selecta Biosciences Inc
HLIO Helios Technologies Inc
AOUT American Outdoor Brands Inc
ZD Ziff Davis Inc
AGAC African Gold Acquisition Corp
LEA Lear Corp
PRT PermRock Royalty Trust
Go

Company profile

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The Company's BioCorRx Recovery Program is a non-addictive, medication-assisted treatment (MAT) program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. It is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Its products include BICX101 and BICX104. Its lead candidate, BICX101, is a sustained release, injectable naltrexone for the treatment of opioid abuse and alcoholism. It is also developing an implantable naltrexone treatment, BICX104, a long-acting naltrexone implant that can last several months for the treatment of opioid dependence and alcohol use disorders. Its subsidiary is BioCorRx Pharmaceuticals, Inc.

Closing Price
$2.50
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.50
Day's Low
2.48
Volume
(Heavy Day)
Volume:
15,452

10-day average volume:
2,687
15,452

Display:

Providers:

UpdateCancel
4 providers

No article found.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.